In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking

OBJECTIVE: To seek potential Chinese herbal medicine (CHM) for the treatment of coronavirus disease 2019 (COVID-19) through the molecular docking of the medicine with SARS-CoV-2 3CL hydrolytic enzyme and the angiotensin converting enzyme II(ACE2) as receptors, using computer virtual screening techni...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Liang-qin, Xu, Jing, Chen, Shao-dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338104/
https://www.ncbi.nlm.nih.gov/pubmed/32632717
http://dx.doi.org/10.1007/s11655-020-3476-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338104/
https://www.ncbi.nlm.nih.gov/pubmed/32632717
http://dx.doi.org/10.1007/s11655-020-3476-x

Ejemplares similares